Patents Assigned to LogicBio Therapeutics, Inc.
  • Manufacturing and use of recombinant AAV vectors
    Patent number: 11814642
    Abstract: Presented herein are technologies and methods for improved production of AAV vectors.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: November 14, 2023
    Assignee: LogicBio Therapeutics, Inc.
    Inventors: Matthias Charles Jerome Hebben, Jing Liao, Carmen Wu, Wilhad Hans Reuter, Thomas Matthew Edwards
  • NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA
    Publication number: 20220218843
    Abstract: Methods and technologies for the treatment of methylmalonic acidemia.
    Type: Application
    Filed: October 30, 2018
    Publication date: July 14, 2022
    Applicant: LogicBio Therapeutics, Inc.
    Inventors: Charles P. Venditti, Randy J. Chandler, B. Nelson Chau, Kyle P. Chiang, Jing Liao